Aroa Biosurgery Ltd. engages in the development, manufacturing, and marketing of soft tissue repair products. The company develops, manufactures, sells, and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Its products are developed from the AROA extracellular matrix (ECM) technology platform, an extracellular matrix biomaterial derived from the ovine forestomach. AROA ECM is an ECM biomaterial containing a rich and complex mix of biological molecules that serve as the building blocks for a range of soft tissue repair products. Its products include Endoform, Myriad Matrix, Myriad Morcells, Myriad Morcells Fine, Symphony, and Reinforced Bioscaffolds. Endoform products support all phases of wound healing and are appropriate for use early in wound management to restore protease balance and advance healing to the proliferative phase. Myriad Matrix is an engineered ECM designed for soft tissue repair, reinforcement, and complex wounds.
Follow-Up Questions
¿Qué tal es el rendimiento del precio de la acción AROAF?
El precio actual de AROAF es de $0.4589, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Aroa Biosurgery Ltd?
Aroa Biosurgery Ltd pertenece a la industria Biotechnology y el sector es Health Care
¿Cuál es la capitalización bursátil de Aroa Biosurgery Ltd?
La capitalización bursátil actual de Aroa Biosurgery Ltd es $158.6M
¿Es Aroa Biosurgery Ltd una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 6 analistas han realizado calificaciones de análisis para Aroa Biosurgery Ltd, incluyendo 2 fuerte compra, 5 compra, 2 mantener, 0 venta, y 2 fuerte venta
